Evolent Health Inc (EVH)
22.88
-0.39
(-1.68%)
USD |
NYSE |
May 23, 16:00
22.88
0.00 (0.00%)
After-Hours: 17:14
Evolent Health Revenue (Quarterly): 639.65M for March 31, 2024
Revenue (Quarterly) Chart
Historical Revenue (Quarterly) Data
| Date | Value |
|---|---|
| March 31, 2024 | 639.65M |
| December 31, 2023 | 556.06M |
| September 30, 2023 | 511.02M |
| June 30, 2023 | 469.14M |
| March 31, 2023 | 427.69M |
| December 31, 2022 | 382.43M |
| September 30, 2022 | 352.58M |
| June 30, 2022 | 319.94M |
| March 31, 2022 | 297.06M |
| December 31, 2021 | 248.36M |
| September 30, 2021 | 222.47M |
| June 30, 2021 | 222.06M |
| March 31, 2021 | 215.07M |
| December 31, 2020 | 246.54M |
| September 30, 2020 | 239.57M |
| June 30, 2020 | 217.30M |
| March 31, 2020 | 221.23M |
| December 31, 2019 | 77.26M |
| September 30, 2019 | 220.14M |
| June 30, 2019 | 191.96M |
| March 31, 2019 | 197.76M |
| Date | Value |
|---|---|
| December 31, 2018 | 193.10M |
| September 30, 2018 | 149.95M |
| June 30, 2018 | 144.30M |
| March 31, 2018 | 139.71M |
| December 31, 2017 | 113.73M |
| September 30, 2017 | 107.91M |
| June 30, 2017 | 107.07M |
| March 31, 2017 | 106.24M |
| December 31, 2016 | 88.01M |
| September 30, 2016 | 60.21M |
| June 30, 2016 | 56.52M |
| March 31, 2016 | 49.45M |
| December 31, 2015 | 46.06M |
| September 30, 2015 | 40.41M |
| June 30, 2015 | 10.41M |
| March 31, 2015 | |
| December 31, 2014 | |
| September 30, 2014 | |
| June 30, 2014 | |
| March 31, 2014 | 20.08M |
Revenues Definition
Revenues measure the total amount of value that a company brings in during a certain period. This is also considered the "top-line" of the income statement. Revenues are used for all operating expenses as well as other line items which eventually lead to the net income for the company. Revenue is an extremely important metric when analyzing a company. A company with efficient margins is able to turn revenues into the most net income.
Revenue (Quarterly) Range, Past 5 Years
77.26M
Minimum
Dec 2019
639.65M
Maximum
Mar 2024
313.88M
Average
247.45M
Median
Revenue (Quarterly) Benchmarks
| American Shared Hospital Services | 5.216M |
| Novo Integrated Sciences Inc | 3.171M |
| Astrana Health Inc | 404.36M |
| Cryo-Cell International Inc | 7.852M |
| P3 Health Partners Inc | 388.49M |
Revenue (Quarterly) Related Metrics
| Net Income (Quarterly) | -17.28M |
| Total Expenses (Quarterly) | 644.15M |
| EPS Diluted (Quarterly) | -0.22 |
| Enterprise Value | 3.101B |
| Gross Profit Margin (Quarterly) | 16.28% |
| Profit Margin (Quarterly) | -2.70% |
| Earnings Yield | -5.46% |
| Normalized Earnings Yield | -3.329 |